BRCA1 and breast carcinoma: With the increased instance of highly invasive breast cancer in individuals with mutations in BRCA, the identification of other factors that mimic the ability of BRCA1 to maintain genomic stability would expand our repertoire of oncogenic markers and increase our ability to design targeted treatments for breast cancer patients.